These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 3041612)

  • 1. Fosfomycin.
    Yeo M
    Singapore Med J; 1988 Apr; 29(2):91-2. PubMed ID: 3041612
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
    Olay T; Vicente MV; Rodríguez A
    J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
    [No Abstract]   [Full Text] [Related]  

  • 3. [Staphylococcus aureus resistant to cloxacillin: treatment with fosfomycin-rifampicin].
    Wolff M; Nercelles P; Pepay K
    Rev Med Chil; 1984 Jul; 112(7):665-71. PubMed ID: 6569621
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fosfomycin prescription during production shortage].
    Dinh A; Bru JP; Dresco I; Janus C; Bernard L
    Med Mal Infect; 2008 Jul; 38(7):383-6. PubMed ID: 18550311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental endocarditis and fosfomycin.
    Rodríguez A; Vicente MV; Olay T
    Drugs Exp Clin Res; 1985; 11(1):55-62. PubMed ID: 3836112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Importance of the cefotaxime-fosfomycin combination. Apropos of a case of meningitis due to heterogeneously resistant Staphylococcus aureus].
    Tremeaux JC; Duez JM; Pechinot A; Sautreaux JL; Thierry A; Kazmierczak A
    Agressologie; 1983 Apr; 24(4):169-71. PubMed ID: 6314832
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
    Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
    Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fosfomycin--a new antibiotic in rhinootolaryngology].
    Stammberger H
    HNO; 1983 Dec; 31(12):436-9. PubMed ID: 6662741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Experience with fosfomycin in the treatment of severe infections in a pediatric intensive care unit].
    Lagier P; Perraud-Bimar P; Dejode JM; Brun T; Bimar J
    Ann Pediatr (Paris); 1987 Jun; 34(6):457-61. PubMed ID: 3619317
    [No Abstract]   [Full Text] [Related]  

  • 11. Penicillin G-resistant staphylococcal infections.
    Med Lett Drugs Ther; 1966 Jun; 8(12):45-6. PubMed ID: 4958196
    [No Abstract]   [Full Text] [Related]  

  • 12. [Value of the aminoglycoside-fosfomycin combination. Apropos of a case of bacterial endocarditis].
    de Boutin JL; Manuel C; Charrel J; Aubert C; Mallet MN; Gevaudan MJ; Malmejac C; Houel J
    Pathol Biol (Paris); 1985 Jun; 33(6):684-6. PubMed ID: 3900889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in the ventricular and serum levels of fosfomycin during treatment of 5 cases of coagulase-negative staphylococcal ventriculitis].
    Scontrini G; Boulard G; Quentin C; Pouguet P; Besse JL; Viallefont E; Sabathié M
    Agressologie; 1983 Apr; 24(4):165-7. PubMed ID: 6638289
    [No Abstract]   [Full Text] [Related]  

  • 14. [Update on antibiotic therapy. 17) A combination of fosfomycin and cephalexin (cefemic cofosfolactamine)].
    Di Nola F
    Minerva Med; 1983 May; 74(20):1217-22. PubMed ID: 6379514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of ventriculitis caused by Staphylococcus epidermidis on equipment with the combination of fosfomycin and an aminoglycoside. Course of ventricular levels of fosfomycin].
    Boulard G; Quentin C; Scontrini G; Dautheribes M; Pouguet P; Sabathie M
    Pathol Biol (Paris); 1983 Jun; 31(6):525-7. PubMed ID: 6348662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New trends in the chemotherapy of staphylococcal infections.
    Russo G; Tempera G; Stefani S; Nicoletti G
    Chemioterapia; 1986 Apr; 5(2):116-9. PubMed ID: 3635440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of phosphonomycin in experimental animals.
    Borowski J; Borowski E; Bobrowski M; Dzier-Zanowska D; Jakoniuk P; Zaremba M
    Rocz Akad Med Im Juliana Marchlewskiego Bialymst; 1977; 22():3-9. PubMed ID: 100861
    [No Abstract]   [Full Text] [Related]  

  • 18. Community-acquired methicillin-resistant Staphylococcus aureus infections--Michigan.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1981 May; 30(16):185-7. PubMed ID: 6789075
    [No Abstract]   [Full Text] [Related]  

  • 19. [The problem of the clinical significance of methicillin and oxacillin-resistant staphylococci].
    Hirsch HA
    Med Welt; 1966 Oct; 42():2226-9. PubMed ID: 5182647
    [No Abstract]   [Full Text] [Related]  

  • 20. Methicillin-resistant Staphylococcus aureus.
    Sheppard M
    Occup Health (Lond); 1988 Mar; 40(3):476-9. PubMed ID: 3374923
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.